BioCentury
ARTICLE | Company News

Inovio, University of Pennsylvania deal

January 18, 2010 8:00 AM UTC

The partners added DNA vaccine technology against pandemic influenza, Chikungunya, foot-and-mouth disease and chemokine and cytokine molecular adjuvant technologies to a 2007 deal. Under the original ...